Navigation Links
Virtuoso(R) Affirms Travel Amidst H1N1 Flu Scare
Date:5/6/2009

Virtuoso Highlights Precautions, Policy Changes And Reasons For Using A Knowledgeable Travel Advisor As The Swine Flu Continues To Concern Travelers

NEW YORK, May 6 /PRNewswire/ -- The sudden outbreak of the H1N1 virus, more commonly known as the swine flu, caught the world by surprise, causing opinions to become unsubstantiated rumors over the health risks currently associated with travel. Leading luxury travel network, Virtuoso, has reached out to its 6,000+ travel advisors and 1,200 preferred travel providers to get the facts on travel now.

Most travel providers are well-versed in issues of public health, having weathered previous bouts with SARS, avian flu and the occasional report of Norwalk virus. Virtuoso's travel providers have reported precautionary measures already in place, and have escalated their practices to counter potential risks to passengers. Cruise lines instituted global screening of all passengers for flu-like symptoms in addition to their standard sanitation and on-board medical protocols; many are also bypassing ports in Mexico through mid- to end of May. Airlines have reported use of air filtration systems similar to those found in hospitals, and they employ crews trained in handling passengers who become ill. Many airlines and hotels have temporarily waived change fees and are offering some refunds for travel to Mexico.

Virtuoso says its professional travel advisors have seen few cancellations, with most of their clientele redirecting trips from Mexico to the Caribbean, and the Dominican Republic in particular. "Travel through a Virtuoso advisor offers support and advocacy. Knowledge of destinations, supplier practices, insurance and in-country assistance should the traveler require it -- these are all standard services provided to our clientele," says Kristi Jones, president of Virtuoso. "Travel provides the certainty of shared experiences and deep connections with loved ones and friends, of lasting memories that few wish to do without. Perhaps that's why our advisors reported a seven point gain in travel in the first quarter of the year."

Virtuoso states that while the flu's effect on humans is undeniably tragic, one of the very real casualties of this outbreak has been the already ailing economy. Mexico City alone is estimating losses at over $60 million a day. The SARS epidemic in 2003, while equally short-lived, cost the world's economy $40 billion dollars. Travel and Tourism is a cornerstone for many countries' financial well-being, contributing nearly 10 percent to the world's economy, as well as helping maintain the world's cultural and historical heritage and supporting the preservation of our natural environment.

"Most travelers understand their role as global citizens and Virtuoso's clients, who are affluent and international travelers, reflect this philosophy, knowing that their travel is beneficial to their families and the world's well-being," continued Jones. Jones' statement is supported by WHO spokesman, Gregory Hartl, who said in reference to the 2003 SARS epidemic, "Border controls do not work. Travel restrictions do not work. There was much more economic disruption caused by their measures than there was public health benefit."


'/>"/>
SOURCE Virtuoso(R)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Smithfield Foods Reaffirms No Incidence of A(H1N1) In Any of Its Herds or Employees
2. Sanofi-aventis Affirms Its Commitment to Partnering with Local Communities to Improve Hispanic and African American Health
3. Amber Court Assisted Living Communities Reaffirms Its Commitment To Seniors On Medicaid
4. Amber Court Assisted Living Communities Reaffirms its Commitment to Seniors on Medicaid
5. Genesis Pharmaceuticals Affirms Operating Income Guidance, Adjusts Revenue Guidance for Fiscal 2009
6. Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent; Claims Against TAXUS Liberte Dismissed
7. RiskMetrics Affirms Recommendation that Stockholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
8. Fitch Affirms ProAssurances Rating and Stable Outlook
9. ESC reaffirms advice on cardiovascular risks associated with long-haul flights
10. China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update
11. Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: